Company news

PROCEPT BioRobotics Corporation news in 2024

PROCEPT BioRobotics Corporation's news releases, calls and decks from 2024, newest first.

View company

PROCEPT BioRobotics to Present at Upcoming 36th Annual Piper Sandler Healthcare Conference on December 4, 2024

November 25, 2024

PROCEPT BioRobotics Corporation Announces Pricing of Offering of Common Stock

October 28, 2024

PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance

October 27, 2024

PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock

October 27, 2024

PROCEPT BioRobotics to Report Third Quarter 2024 Financial Results on October 28, 2024

October 8, 2024

PROCEPT BioRobotics Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical Study for Prostate Cancer

October 6, 2024

PROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024

August 27, 2024

PROCEPT BioRobotics Announces FDA Clearance of the HYDROS™ Robotic System, the Next-Generation, AI-Powered Platform for Aquablation® Therapy

August 20, 2024

PROCEPT BioRobotics® Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue and EBITDA Guidance

July 31, 2024

PROCEPT BioRobotics to Report Second Quarter 2024 Financial Results on August 1, 2024

July 14, 2024

PROCEPT BioRobotics Announces New CPT® Category I Code from the American Medical Association for Aquablation therapy

June 16, 2024

PROCEPT BioRobotics to Present at Upcoming 2024 Truist Securities MedTech Conference on June 18, 2024

June 2, 2024

PROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock Conference

May 12, 2024

Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia

May 5, 2024

PROCEPT BioRobotics Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance

April 30, 2024

Late Breaking Abstract Presented at the Japanese Urological Association Annual Meeting on Aquablation Therapy Outcomes for Men in Japan with Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia

April 28, 2024

PROCEPT BioRobotics Announces 12 Scientific Research Presentations on Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia at the 2024 AUA Annual Meeting

April 22, 2024

PROCEPT BioRobotics Corp. Announces Investor Event at 2024 AUA Annual Meeting in San Antonio, Texas

April 3, 2024

PROCEPT BioRobotics to Report First Quarter 2024 Financial Results on May 1, 2024 and Attend the 2024 Bank of America Healthcare Conference on May 15, 2024

April 1, 2024

PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2023 Results

February 26, 2024

PROCEPT BioRobotics to Present at the 44th Annual TD Cowen Health Care Conference in Boston

February 11, 2024

PROCEPT BioRobotics® Announces Preliminary Fourth Quarter Revenue of $43.3 million to $43.6 million

January 7, 2024

Calls in 2024

Decks in 2024